Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;34(8):512-517.
doi: 10.1177/09564624231165547. Epub 2023 Mar 27.

A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries

Affiliations
Review

A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries

Hannah A Segal et al. Int J STD AIDS. 2023 Jul.

Abstract

Background: Understanding the cost-effectiveness of the HPV vaccine from a global perspective is important to assess from a policy perspective and to support current and future HPV vaccination programs.

Objectives: The aim of this analysis was to conduct a targeted literature review of published pharmacoeconomic literature on the cost-effectiveness of the HPV vaccine to treat patients in various countries, with a focus on cost-savings and their impact on vaccine recommendations.

Methods: We searched cost-effectiveness studies in HPV published in peer-reviewed literature from 2012 to 2020 using MEDLINE via the PubMed database and Google Scholar.

Results: HPV vaccine cost-effectiveness was found to be greatest in low-income countries where screen programs were not yet in place, additionally, in adolescent males and females. The majority of the economic evaluations viewed the implementation of the HPV vaccine as cost-effective and recommended national HPV vaccination.

Conclusion: The majority of economic studies favored national HPV vaccination for adolescent males and females in various countries. Feasibility of this strategy and implementation remains an open question, in addition to screening coverage rate in countries with no vaccine programs or countries yet to introduce national HPV vaccination.

Keywords: Human papillomavirus vaccine; cervical cancer prevention; economic analysis; literature review.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow diagram of the included studies by search strategy.

Similar articles

References

    1. Genital HPV infection – CDC fact sheet . Centers for disease Control and prevention. Washington DC: Department of Health & Human Services, www.cdc.gov/std/hpv/hpv-Fs-July-2017.pdf (2017, accessed 14 January 2022).
    1. HPV infection . Mayo Clinic. Rochester MN: Mayo Foundation for Medical Education and Research (MFMER), www.mayoclinic.org/diseases-conditions/hpv-infection/symptoms-causes/syc... (2021, accessed 27 January 2022).
    1. Smith SS, Hilas O. Human Papillomavirus primer for pharmacists. New York NY: US Pharmacist, www.uspharmacist.com/article/human-papillomavirus-primer-for-pharmacists (2022, accessed 16 December 2022).
    1. Luria L, Cardoza-Favarato G. Human Papillomavirus. StatPearls. Bethesda MD: National Library of Medicine, www.ncbi.nlm.nih.gov/books/NBK448132/ (2022, accessed 12 May 2022).
    1. Hathaway JK. HPV Diagnosis, Prevention, and Treatment. Clin Obstet Gynecol 2012; 55: 671–680. - PubMed

Substances